The Carbapenem Based Antibiotics Market
size is projected to reach US$ 5,346.62 million by 2028 from US$ 3,964.57
million in 2021; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028.

Generic versions of antibiotics are popular due to their
availability and affordability. In addition, the expiry of patented
carbapenem-based antibiotics has widen-up opportunities for generic drug
manufacturers to enter the market with their cost-efficient drugs. The focus of
generic drug producers is to increase the reach of these drugs. Moreover, the shortage
of antibiotics to treat bacterial infections is also one of the prime factors
driving the market's growth. The increased production of generic
carbapenem-based antibiotics has enlarged the drug availability in various low-
and middle-income countries.

Get a Sample PDF of report at- https://www.premiummarketinsights.com/sample/TIP00073365

The List of Companies -  

1.      
Pfizer Inc.

2.      
Savior
Lifetec

3.      
Sumitomo
Dainippon Pharma Co., Ltd.

4.      
Merck &
Co., Inc.

5.      
Gland Pharma
Limited

6.      
Aurobindo
Pharma Ltd

7.      
Daewoong
Pharmaceutical Co.,Ltd,

8.      
Iterum
Therapeutics plc

9.      
ACS Dobfar
S.p.A

10.  
Spero
Therapeutics

Based on
geography, the carbapenem-based antibiotics market is segmented into North
America, Europe, Asia Pacific, Middle East and Africa, and South and Central
America. North America dominates the global market share and is expected to
hold its strong foothold in the coming years. The region is expected to witness
a consistent growth in the future owing to factors such as increased adoption
of carbapenem based antibiotics, high prescription rate of antibiotics, and
advancements in research and development leading to the emergence and launch of
new medicines. However, the market in Asia Pacific is expected to witness the
fastest growth in the coming years. The carbapenem-based antibiotics market
size in India and China is expected to grow rapidly owing to factors such as
the large population, increasing focus of market players on developing novel
vaccines and products at affordable prices, and high penetration of market players
manufacturing generic drugs and exporting them across the world.

Generic versions of carbapenem drugs available in the market
are ertapenem (Invanz), imipenem/cilastatin (Primaxin IM), doripenem (Doribax),
and meropenem (Merrem). In addition, the growing number of generic players in
the market is accelerating the production of generic drugs. Many Asian
companies are engaged in developing active pharmaceutical ingredients (API),
which are required to produce generic carbapenem-based antibiotics. In June
2021, JW Pharmaceutical, a South Korean company, announced it had completed
production of its API for Ertapenem injection and shipped it to the US. The
company plans to enter the global carbapenem antibiotic market in the coming
years. It has also succeeded in developing its technology independently in Korea
to produce Doripenem. Furthermore, the company plans to expand the sales of
both API and finished drugs of Imipenem and Meropenem by exporting them to over
40 countries, including China and Japan. As a result, companies are
accelerating generic drug production and driving the growth of the global
carbapenem-based antibiotics market.

Buy a copy
of this research report at @: https://www.premiummarketinsights.com/buy/TIP00073365

TABLE OF CONTENTS

1. Introduction

   1.1 Scope of the Study

   1.2 Research Report Guidance

   1.3 Market Segmentation

         1.3.1 By Type

         1.3.2 By Indication

         1.3.3 By Distribution Channel

         1.3.4 By Geography

2. Key Takeaways

3. Research Methodology

   3.1 Coverage

   3.2 Secondary Research

   3.3 Primary Research

4. Market Landscape

   4.1 Overview

   4.2 PEST Analysis

         4.2.1 North America- PEST Analysis

         4.2.2 Europe- PEST Analysis

         4.2.3 Asia Pacific- PEST Analysis

         4.2.4 Middle East and Africa- PEST
Analysis

         4.2.5 South and Central America- PEST
Analysis

   4.3 Expert Opinions

5. Key Market Dynamics

   5.1 Drivers

         5.1.1 Rising Prevalence of
Gram-Negative Bacterial Infections

         5.1.2 Increasing Production of Generic
Drugs

   5.2 Market Restraints

         5.2.1 Tedious and Expensive Process of
Antibiotic Development

   5.3 Market Opportunities

         5.3.1 Private and Public Partnerships

   5.4 Future Trends

         5.4.1 Strategic Advancement for New
Antibiotic Identification

   5.5 Impact Analysis

6. Global Analysis

7. By Type

8. By Indication

Continued…

About Us:

Premium Market Insights is a one
stop shop of market research reports and solutions to various companies across
the globe. We help our clients in their decision support system by helping them
choose most relevant and cost-effective research reports and solutions from
various publishers.

The market research industry has
changed in last decade. As corporate focus has shifted to niche markets and
emerging countries, a number of publishers have stepped in to fulfil these
information needs. We have experienced and trained staff that helps you
navigate different options and lets you choose best research solution at most
effective cost.

Premium Market Insights has an
extensive coverage of industry reports, company reports and country reports
across all industries. In case your research needs are not met by syndicated
reports offered by leading publishers, we can help you by offering a customized
research solution by liaising with different research agencies saving your
valuable time and money.

We provide best in class customer
service and our customer support team is always available to help you on your
research queries. Our commitment to customer service is best exemplified by
free analyst support that we offer to our clients which sets us apart from any
other provider. We also offer enterprise subscriptions which provide
significant cost savings to our clients.

Contact Us:

If you have any queries about
this report or if you would like further information, please

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email:
sales@premiummarketinsights.com

Carbapenem-Based
Antibiotics Market Scenario, Carbapenem-Based Antibiotics Market Research,
Carbapenem-Based Antibiotics Market Industry, Carbapenem-Based Antibiotics
Market Segmentation, Carbapenem-Based Antibiotics Market Companies,
Carbapenem-Based Antibiotics Market Manufacture, Carbapenem-Based Antibiotics
Market Overview, Carbapenem-Based Antibiotics Market Share, Carbapenem-Based
Antibiotics Market Survey, Carbapenem-Based Antibiotics Market Regions,